Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP<br />
67<br />
Staffing is as follows:<br />
Study Nurses 1 Data Entry Clerk Pharmacy Staff Laboratory Staff Admin<br />
4 (2 full time/ 2 1 0 0 3*<br />
part time)<br />
* 1 Manager (who is also one of the study nurses), 1 Assistant, 1 Financial Director.<br />
The unit uses the hospital pharmacy in its conduct of clinical trials if necessary. Laboratory tests are<br />
conducted at the hospital or private laboratories.<br />
Quality control/ assurance procedures are based on detailed <strong>and</strong> extensive St<strong>and</strong>ard Operating Procedures<br />
<strong>and</strong> are compliant with ICH, Health Canada, <strong>and</strong> FDA Good <strong>Clinical</strong> Practice (GCP) guidelines.<br />
All projects are approved by the REB prior to initiation <strong>and</strong> all research staff are trained appropriately in<br />
clinical trials, GCP regulations <strong>and</strong> guidelines, <strong>and</strong> the SOPs. The Unit also participates in monitor <strong>and</strong><br />
study termination visits <strong>and</strong> audits.<br />
Contact:<br />
Breakwell, Lynn. RN. Tel: 604-587-3720. lynn.breakwell@fraserhealth.ca.<br />
Fraser Health Critical Care Group<br />
Critical Care research in Fraser Health is conducted at Surrey Memorial (SMH) <strong>and</strong> Royal Columbian<br />
(RCH) Hospitals (http://research.fraserhealth.ca/clinical_trials/clinical_trials_research_groups/). The<br />
focus of the research program is on contributing to publicly funded trials, [e.g. Thromboprophylaxis;<br />
ARDS; Sedation management, <strong>Life</strong> support outcomes for Octogenarians; Ventilator Associated Pneumonia;<br />
H1N1] largely in collaboration with the highly successful Canadian Critical Care <strong>Trials</strong> Group. Other<br />
research includes industry funded studies [e.g. Sepsis; Surfactant in Acute Lung Injury; Novel Vasopressors]<br />
<strong>and</strong> small investigator driven pilot studies [e.g. Topical antibiotics to reduce central line infections,<br />
dosing of antibiotics in non dialysis dependent renal failure]. Industry-sponsored trials include Phases II<br />
<strong>and</strong> III.<br />
The key Principal Investigators are:<br />
• Reynolds, Steven (Intensivist <strong>and</strong> ICU Research Director, Royal Columbian Hospital)<br />
• Keenan, Sean.<br />
Their details can be found in Appendix 6.<br />
Contact:<br />
Svetik, Miroslav. ICU RCH Research Coordinator. miroslav.svetik@fraserhealth.ca.<br />
Mans, Sheilagh. ICU SMH Research Coordinator. Sheilagh.Mans@fraserhealth.ca.<br />
Multiple Sclerosis Clinic<br />
Based at Burnaby Hospital, the Fraser Health Multiple Sclerosis clinic provides a comprehensive, community<br />
based clinic to the Fraser Health region (http://research.fraserhealth.ca/clinical_trials/clinical_trials_research_groups/).<br />
The clinic has 13 multidisciplinary team members (4 neurologists, urologist,<br />
neuro-ophthalmologist, psychiatrist, rehab medicine, MS certified nurse, physical therapist, occupa-